Curocell
The company is committed to developing innovative technologies to improve the efficacy of cancer treatments and address the limitations of traditional cancer immunotherapy drugs.
Launch date
Employees
Market cap
-
Enterprise valuation
$121—181m (Dealroom.co estimates Jan 2022.)
Company register number 1488800557
South Korea (HQ)
Authorizing premium user...